Stem Cells meetings & conferences

Stem Cells Forum: Working Towards Clinical Application

Wednesday, 03 October 2012 09:00 - 17:00

London, United Kingdom

This event is discussion forum, focused on clinical applications of stem cell therapy. The aim is to offer participants a chance to explore aspects with the experts during round table and one-to one discussions.

Meeting Chair: Dr Glyn Stacey, UK Stem Cell Bank, Division of Cell Biology and Imaging.

Contact Details

Meeting Secretariat Email: astrid.englezou@euroscicon.com

General Enquires Email: enquiries@euroscicon.com

12th International Symposium on Myelodysplastic Syndromes

May 8-11, 2013 Berlin, Germany

The scientific program is designed to meet the aims of The MDS Foundation, which are “to provide an ongoing exchange of information relating to MDS and provides patients with referrals to Centers of Excellence, contact names for available clinical trials, sharing of new research and treatment options between physicians, and extension of educational support to both physicians and patients." The format will include plenary sessions (including a nursing symposium), debates, case-based discussion, topical workshops, oral and poster presentations.

This 12th symposium will again promote the clinical application of existing knowledge and the acquisition of new knowledge by bringing together clinicians, scientists and educators from around the world who deal with MDS.

Clinical Management: General
Diagnosis (including morphology, flow cytometry, molecular)
Epidemiology (including demographics, quality of life, co-morbidity)
Pathogenesis (including molecular, immunological, cellular, animal models, other)
Childhood MDS
Prognostic Factors and Models
Supportive Care including Iron Chelation Therapy
Stem Cell Transplantation
Therapy (including high-risk MDS, low-risk MDS, other)
Other

Joint Meeting of the American Pancreatic Association and the International Association of Pancreatology

October 31 - November 3, 2012 Miami, Florida

The 2012 Annual Meeting of the American Pancreatic Association (APA) to be held jointly with the International Association of Pancreatology (IAP) will take place at the Eden Roc Renaissance in Miami Beach FL from Oct 31-Nov 3. The meeting will include several mini-symposia in addition to abstract driven sessions including a symposia on Pancreatic Stem Cells and Stellate Cells (organized by Minoti Apte and Diane Simeone on Saturday Nov 3) and a consensus conference open to all participants to update the 2002 IAP Evidence-Based Guidelines on the Management of Acute Pancreatitis (on Wednesday October 31).

Aging and Diseases of Aging

22 Oct 2012 through 27 Oct 2012 Tokyo, Japan

LANGUAGE NOTE: This meeting will be conducted in English.

Age-related diseases and disabilities, such as cancer, diabetes, and neuronal degeneration, pose an ever increasing social and economic burden worldwide. Fortunately, the last decades have witnessed dramatic progress in our understanding of the aging process. Genetic studies in particular have helped elucidate some of the molecular pathways that regulate the aging and offered new insights into the treatment of age-related diseases. However, there is still much to be learned and further progress in addressing the unique challenges of the aging population will require new insights and novel approaches. In order to accelerate the discovery process, this Keystone Symposia meeting will cover essential aspects of the aging processes, including cell signaling pathways, DNA stability, protein homeostasis, stem cells and cellular senescence. Each plenary session will emphasize innovative findings from a variety of models in basic research areas and link them to age-related disease and frailty. The ultimate goal is to provide an opportunity for attendees to communicate and promote an integrated understanding of aging and age-related diseases. The program for this meeting is highly likely to attract a wide variety of investigators, many of whom might not otherwise interact.

Keystone Symposia
Phone: +1 (800) 253-0685 or +1 (970) 262-1230
Fax: +1 (970) 262-1525
info@keystonesymposia.org

12th International Conference on Cancer-Induced Bone Disease

15 to 17 November, 2012 Lyon, France

The International Meeting on Cancer-Induced Bone Disease is among the most exciting international occasions for the exchange of the latest scientific discoveries. They are designed to allow attendees to enhance their knowledge of diseases of the skeleton, basic bone biology, mineral metabolism, and their correlation to oncology.

Discussions on the latest advances in innovative treatments and cutting-edge practices await you at the 2012 event. The conference takes place 15-17 November 2012 in Lyon, France. The world’s leading scientists and researchers will be on-hand to share their expertise in bone metastases and bone and cancer cell biology.

Learning Objectives
The importance of both the physical and cellular bone microenvironment and the hematopoietic stem cell niche in supporting the growth of metastatic cancer cells
The role of cancer stem cells and hematopoietic stem cells in the metastatic process
The current state of the field of genomics and proteomics as applied to bone metastasis
The efficacy of new therapeutic agents and imaging techniques for bone cancers and bone metastasis
The consequences of tumor cells on the skeleton
Understanding of the mechanisms of therapy resistance

IBMS and CABS meetings are premier international scientific events that provide an international forum to present and discuss current basic and clinical science in the rapidly advancing field of skeletal complications of cancer.

International Bone and Mineral Society (IBMS)
401 N Michigan Ave Chicago, Suite 2200, IL 60611 USA
Phone: +1 312-321-5113 | Fax: +1 312-673-6934 | Email: info@ibmsonline.org

ISEH - Society for Hematology and Stem Cells Annual Scientific Meeting

41st Annual Scientific Meeting - 23-26 August 2012 Amsterdam, Netherlands

The mission of ISEH is to promote the scientific knowledge and clinical application of basic hematology, immunology, stem cell research, cell and gene therapy, and all related aspects through research, publications, discussion, support of young investigators and organization of scientific meetings.
 

IEEE-EMBS Micro- and Nanoengineering in Medicine Conference (MNMC 2012)

Translating Technology from the Bench to the Bedside

December 3-7, 2012 The Westin Maui Resort and Spa, Ka’anapali, Hawaii

Various biomedical grand challenges facing our society and the world can be addressed by interfacing biology and medicine with micro- and nanoscale technologies. These technologies hold great potential to impact early diagnosis, therapeutics, and management of disease. IEEE EMBS is sponsoring the first Conference on Micro- and Nanoengineering in Medicine to foster interaction between scientists, engineers and medical researchers in the context of real-world medical needs and issues. The Conference will promote vigorous and open dialogue towards the development of cutting edge technologies for faster, more quantitative, and less expensive biomedical solutions using advances in micro and nanotechnology.

24th Annual Fanconi Anemia Research Fund Scientific Symposium

September 27 – 30, 2012 Denver, Colorado

Session topics may include:

Bone marrow failure and transplantation
Gene therapy and stem cell expansion
Functions of FA proteins
Role of environmental and endogenous mutagens
Small molecule development and therapeutics
Other experimental therapies
Squamous cell carcinoma and HPV
Other cancers in FA
Molecular pathogenesis and control of hematopoietic and epithelial neoplasms
Pathophysiology and treatment of endocrinopathies

Symposium: Bioethics and Regenerative Medicine

Centre for Applied Philosophy, Politics & Ethics and School of Pharmacy and Biomolecular Sciences, University of Brighton, with the support of Brighton & Sussex Medical School and LABTEC

Monday 16 and Tuesday 17 July 2012: Brighton, United Kingdom

In the last few decades R&D in the biomedical field has been providing therapeutic solutions to a number of clinical applications. In addition to the treatment of diseases triggered by genetic factors, traumatic conditions and serendipity /idiosyncratic causes, many biomedical technologies are applied to the treatment of pathologies related to ageing and lifestyle. Bioethical issues thus need to be discussed not only in the context of the impact of technology on the moral status of biological material and donors/recipients, but also on the basis of its role in the context of saving and/or improving the quality of life: that is to say, in the context of human dignity.

Aim

The aim of the workshop is to analyse bioethical issues in the field of tissue/organ replacement or regeneration -- i.e. regenerative medicine -- where clinical treatments involve the use of medical devices, artificial materials and stem cells (in relation only to cells harvested from adult donors, not from embryos).

Format

A two-day workshop bringing together colleagues in regenerative medicine and in medical- and bioethics for sustained discussion of these and related issues.

Issues

1. Should technology be assessed from a bioethical point of view as something quite separate from biology and its evolution? Or should it rather be framed within the realm of natural processes and their selection mechanisms? Will these two different starting-points lead to different answers to bioethical questions?

2. What is the impact that the perception (or fear) of death and ageing has on individual bioethical views?

3. We all regard quality of life as important. Do the concepts of human integrity and full biological capacity coincide and/or overlap? What is the role of psychological perception in this discourse? Does it make any difference if psychology is itself considered as a ‘product’ of biological evolution?

4. How is bodily integrity to be understood? Is my integrity threatened if an artificial material and/or a donor’s cells are implanted in my body?

5. What are the relations between human dignity and bodily integrity?

6. How might bioethical views change under the pressure of new technologies?

Germline - Immortality Through Totipotency

European Molecular Biology Laboratory Heidelberg, Germany

Saturday 13 October - Tuesday 16 October 2012

Why You Should Attend

Summary
What does immortality mean at the molecular, cellular, transgenerational and evolutionary level?

Most organisms have a defined lifespan, however life of a species continues and evolves via germline from generation to generation. Recent studies show that tissue stem cells share molecular and developmental signatures with the germline and that even fully differentiated, postmitotic cells can be reprogrammed to regain totipotency.

This EMBO | EMBL Symposium will go beyond a description of the phenomena involving stem cell behaviour, programming and reprogramming. It will bring together researchers from different disciplines, who will address fundamental questions of totipotency as they relate to evolution, development and tissue specialization.

Questions to be discussed include:

how a need for germline specification arose during the evolution of multicellularity from single cells to colonies with specialized cell types;

how the fertilized egg cell loses totipotency during formation of a multicelluar organism;

how chromatin-based mechanisms influence totipotency both at the cellular and transgenerational level; and

how the decision toward meiosis is achieved and regulated.

Topics

From single cells to multicellularity

Keeping it all together: chromosomes and chromatin

Programming and reprogramming

Conservative vs progressive divisions (mitosis and meiosis)

Context matters

EMBL Course and Conference Office
European Molecular Biology Laboratory
Meyerhofstraße 1
69117 Heidelberg
Germany

Tel: +49 6221 387 8797
Fax: +49 6221 387 8158